2.9.1.1 Hepatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2681396&form=6&db=m Autoantibodies and antigens in liver diseases--updated. ongoing research,unassigned 2,0 2.9.1.1 Hepatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2880112&form=6&db=m Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. causal interaction,ongoing research,therapeutic application,unassigned 1,2,3,0 2.9.1.1 Hepatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3313682&form=6&db=m [Immunology of liver diseases] diagnostic usage,unassigned 1,0 2.9.1.1 Hepatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7807283&form=6&db=m Detection of autoantibodies against M2, LKM-1, and SLA in liver diseases by standardized uniform ELISA-techniques. diagnostic usage,ongoing research,unassigned 4,2,0 2.9.1.1 Hepatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10952238&form=6&db=m Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis. causal interaction,diagnostic usage,unassigned 1,4,0 2.9.1.1 Hepatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16553048&form=6&db=m [A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis] causal interaction,diagnostic usage,ongoing research,therapeutic application 1,4,2,1 2.9.1.1 Hepatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17274827&form=6&db=m Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis. causal interaction,diagnostic usage,ongoing research,unassigned 4,3,2,0 2.9.1.1 Hepatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19302185&form=6&db=m Significance of antibodies to soluble liver antigen/liver pancreas: a large French study. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,1,0 2.9.1.1 Hepatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21457445&form=6&db=m Identification of T cell epitopes on soluble liver antigen in Chinese patients with auto-immune hepatitis. diagnostic usage,ongoing research,unassigned 2,1,0 2.9.1.1 Hepatitis A http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26061326&form=6&db=m Prognostic Implications of Antibodies to Soluble Liver Antigen in Autoimmune Hepatitis: A PRISMA-Compliant Meta-Analysis. causal interaction,diagnostic usage,therapeutic application,unassigned 2,4,1,0 2.9.1.1 Hepatitis A http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31079040&form=6&db=m False-positive serologies for acute hepatitis A and autoimmune hepatitis in a patient with acute Epstein-Barr virus infection. causal interaction,diagnostic usage,unassigned 1,4,0 2.9.1.1 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2505455&form=6&db=m Histologic features in autoimmune hepatitis. causal interaction,diagnostic usage,therapeutic application,unassigned 1,4,1,0 2.9.1.1 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7747027&form=6&db=m [The clinical laboratory in the diagnosis of autoimmune liver diseases] causal interaction,unassigned 3,0 2.9.1.1 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8224657&form=6&db=m Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,1,1 2.9.1.1 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10551386&form=6&db=m Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,2,0 2.9.1.1 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10801173&form=6&db=m Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. causal interaction,diagnostic usage,ongoing research,unassigned 2,4,1,0 2.9.1.1 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10931155&form=6&db=m Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients withtype-1 autoimmune hepatitis. causal interaction,unassigned 2,0 2.9.1.1 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10934580&form=6&db=m Immunoreactivity to cytokeratin 8/18 in patients with soluble liver antigen (SLA) positive autoimmune hepatitis (AIH type 3) is not sufficient for diagnostic use. diagnostic usage,unassigned 3,0 2.9.1.1 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10952252&form=6&db=m Antibodies to soluble liver antigen: specific marker of autoimmune hepatitis. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,1,0 2.9.1.1 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11230739&form=6&db=m Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis. causal interaction,diagnostic usage,ongoing research,unassigned 4,3,1,0 2.9.1.1 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11826415&form=6&db=m Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas. causal interaction,diagnostic usage,unassigned 4,4,0 2.9.1.1 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11870381&form=6&db=m Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. diagnostic usage,ongoing research,unassigned 4,2,0 2.9.1.1 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14582466&form=6&db=m [Autoimmune hepatitis] diagnostic usage,unassigned 4,0 2.9.1.1 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14981048&form=6&db=m Targets of antibodies to soluble liver antigen in patients with autoimmune hepatitis. causal interaction,diagnostic usage,unassigned 4,4,0 2.9.1.1 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15679947&form=6&db=m Antibodies to soluble liver antigen and alpha-enolase in patients with autoimmune hepatitis. causal interaction,diagnostic usage,unassigned 4,3,0 2.9.1.1 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16553048&form=6&db=m [A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis] causal interaction,diagnostic usage,ongoing research,therapeutic application 1,4,2,1 2.9.1.1 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19712439&form=6&db=m Study of nonstandard auto-antibodies as prognostic markers in auto immune hepatitis in children. causal interaction,unassigned 4,0 2.9.1.1 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20464491&form=6&db=m Autoantibodies as prognostic markers in autoimmune liver disease. causal interaction,therapeutic application,unassigned 4,4,0 2.9.1.1 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20862497&form=6&db=m Discrimination of autoimmune hepatitis: autoantibody typing and beyond. causal interaction,diagnostic usage,unassigned 4,3,0 2.9.1.1 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21745277&form=6&db=m Prognostic implications of antibodies to Ro/SSA and soluble liver antigen in type 1 autoimmune hepatitis. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,4,0 2.9.1.1 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23295051&form=6&db=m Antibodies to soluble liver antigen in patients with various liver diseases: a multicentre study. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,4,2,1 2.9.1.1 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23401700&form=6&db=m Development of a recombinant cell-based indirect immunofluorescence assay for the determination of autoantibodies against soluble liver antigen in autoimmune hepatitis. causal interaction,diagnostic usage,ongoing research,unassigned 4,3,2,0 2.9.1.1 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26061326&form=6&db=m Prognostic Implications of Antibodies to Soluble Liver Antigen in Autoimmune Hepatitis: A PRISMA-Compliant Meta-Analysis. causal interaction,diagnostic usage,therapeutic application,unassigned 2,4,1,0 2.9.1.1 Hepatitis, Autoimmune http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31079040&form=6&db=m False-positive serologies for acute hepatitis A and autoimmune hepatitis in a patient with acute Epstein-Barr virus infection. causal interaction,diagnostic usage,unassigned 1,4,0 2.9.1.1 Hepatitis, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2505455&form=6&db=m Histologic features in autoimmune hepatitis. causal interaction,diagnostic usage,therapeutic application,unassigned 1,4,1,0 2.9.1.1 Hepatitis, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2880112&form=6&db=m Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. causal interaction,ongoing research,therapeutic application,unassigned 1,2,3,0 2.9.1.1 Hepatitis, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3313682&form=6&db=m [Immunology of liver diseases] diagnostic usage,unassigned 1,0 2.9.1.1 Hepatitis, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7807283&form=6&db=m Detection of autoantibodies against M2, LKM-1, and SLA in liver diseases by standardized uniform ELISA-techniques. diagnostic usage,ongoing research,unassigned 4,2,0 2.9.1.1 Hepatitis, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8224657&form=6&db=m Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,1,1 2.9.1.1 Liver Cirrhosis, Biliary http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2737600&form=6&db=m Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. diagnostic usage,unassigned 3,0 2.9.1.1 Liver Cirrhosis, Biliary http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7807283&form=6&db=m Detection of autoantibodies against M2, LKM-1, and SLA in liver diseases by standardized uniform ELISA-techniques. diagnostic usage,ongoing research,unassigned 4,2,0 2.9.1.1 Liver Cirrhosis, Biliary http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20464491&form=6&db=m Autoantibodies as prognostic markers in autoimmune liver disease. causal interaction,therapeutic application,unassigned 4,4,0 2.9.1.1 Liver Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2737600&form=6&db=m Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. diagnostic usage,unassigned 3,0 2.9.1.1 Liver Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8224657&form=6&db=m Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,1,1 2.9.1.1 Liver Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11870381&form=6&db=m Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. diagnostic usage,ongoing research,unassigned 4,2,0 2.9.1.1 Liver Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23295051&form=6&db=m Antibodies to soluble liver antigen in patients with various liver diseases: a multicentre study. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,4,2,1 2.9.1.1 Liver Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24418295&form=6&db=m Diagnostic criteria of autoimmune hepatitis. causal interaction,therapeutic application,unassigned 3,1,0 2.9.1.1 Liver Failure http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20464491&form=6&db=m Autoantibodies as prognostic markers in autoimmune liver disease. causal interaction,therapeutic application,unassigned 4,4,0 2.9.1.1 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29252180&form=6&db=m Folliculotropic Mycosis Fungoides Associated with Autoimmune Hepatitis. causal interaction,diagnostic usage,unassigned 1,4,0 2.9.1.1 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23500141&form=6&db=m Selenium homeostasis and antioxidant selenoproteins in brain: Implications for disorders in the central nervous system. unassigned - 2.9.1.1 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27576344&form=6&db=m Structural basis for early-onset neurological disorders caused by mutations in human selenocysteine synthase. causal interaction,unassigned 3,0 2.9.1.1 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22708491&form=6&db=m Post-transcriptional control of selenoprotein biosynthesis. causal interaction,unassigned 4,0